The mechanism of radiation action in leukaemogenesis. The role of radiation in leukaemia development. by Haran-Ghera, N.
739
THE MECHANISM OFRADIATIONACTION INLEUKAEMOGENESIS.
THE ROLE OF RADIATION IN LEUKAEMIA DEVELOPMENT
NECHAMA HARAN-GHERA
From the Department of Experimental Biology, Weizmann In8titute ofScience,
Rehovoth, Israel
Received for publication June 28, 1967
RADIATION-INDUCED tumours in low leukaemic strains are actually produced
by a virus-like agent (Gross, 1958; Lieberman and Kaplan, 1959; Jenkins and
Upton, 1963), which is apparently also present in these strains, in postnatal life
before exposure to radiation. The presence ofthe virus, however, in normal mice
of these susceptible strains, is not sufficient for the development of the disease.
Radiation or chemical carcinogens are needed to produce a sequence of events,
modifying the host-leukaemogenic agent relationship, for the actual development
of leukaemia. How do these leukaemogenic agents act? Kaplan (1964) has
proposed that radiation produces three simultaneous effects which are essential
for leukaemogenesis: (1) injury to the normal sites ofstorage ofthe leukaemogenic
agent, with its concomitantrelease; (2) injurytothe thymus, followed by aregener-
tion process; and (3) injury to the bone marrow which, in turn, interferes with the
regeneration ofthe irradiated thymus, producing an arrest ofmaturation, in which
large numbers ofhighly immature lymphoid cells are made available for a sustained
period, for the oncogenic expression of the leukaemogenic agent. The role of
injury to thymus and bone marrow in leukaemogenesis has been well established
(Kaplan, 1957), while experimental evidence for the " release " phenomenon has
been obtained in our laboratory (Haran-Ghera, 1966) by searching for a trans-
missible leukaemogenic agent in non-leukaemic tissues taken from irradiated
mice at different intervals after the last fractionated irradiation. The use of a
sensitive technique for testing the leukaemogenic activity of filtrates was a major
contribution in establishing these findings. This sensitive technique consists of
injecting a cell-free filtrate directly into a several-day-old thymus implant under
the kidney capsule in thymectomized irradiated hosts (550 Rwhole-body exposure).
Irradiation of the host is apparently an essential factor for the development of
lymphomas inthis testing system. Ifirradiation is omitted, there is a verymarked
reduction in the incidence of lymphoid tumours, even though the leukaemogenic
agent is inoculated in abundance into a several-day-old growing thymus with many
large and medium lymphocytes, which have been proposed by Kaplan (1961)
and Axelrad and Van der Gaag (1962) as the susceptible cells for neoplatic trans-
formation. This observation on the importance of host irradiation in leukaemia
development has led us to assume that radiation may produce an additional effect
to those proposed by Kaplan, namely, the transient depression of immunologic
responsiveness of the host.
The aim of the present work was to provide some experimental data in favour
ofthis hypothesis. The use ofthe sensitive testing system ofinjecting the leukae-
mogenic filtrate into a several-day-old thymus implant under the kidney capsule
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tested experimentally, using the following procedures: (1) production of immune
reactivation of the irradiated host and the study of its effects on leukaemia inci-
dence; (2) evaluation ofthe relationship between the radiation dose applied to the
host (using also low doses that do not cause immune impairment) and the duration
of its effectiveness in relation to lymphoma incidence; and (3) determination of
the type of defects in the immunologically impaired mice induced by the optimal
radiation dose used in the testing system at different time intervals after exposure,
by studying two different systems: (a) the capacity for circulating antibody
formation in the irradiated mice, using Shigella as the antigen, injected at different
intervals after host irradiation; and (b) the homograft type reaction, using a
benzopyrene-induced C3H sarcoma, which is strain specific and shows progressive
growth only in mice of their strain of origin or in immunologically impaired mice.
We also studied the possibility of delaying the exposure of the host to irradiation
for different intervals after the inoculation of the leukaemogenic agent.
MATERIALS AND METHODS
The source of the C57B1/6 mice, their diet and maintenance, the physical
conditions of irradiation and the preparation and testing of the leukaemogenic
agent, were the same as those described in the foregoing communication (Haran-
Ghera and Peled, 1967). The source of the leukaemogenic transmissible passage
material used in the present studies was the original cell-free centrifugates pre-
pared from tissues taken from donors treated simultaneously with X-rays and
urethane 10 days after completion of the treatment (Haran-Ghera, 1966). The
first passage ofthis leukaemogenic ifitrate was begun during January-March 1965,
and we have already obtained the tenth passage, which produces 70-90 per cent
lymphoma development in the inoculated mice at a mean latent period of 85-120
days.
The leukaemogenic potency of the filtrate was routinely tested in thymectom-
ized mice exposed to 550 R whole-body irradiation; the effectiveness ofother doses
ofX-rays, ranging from 150-550 R whole-body exposure, in the host mice was also
tested. The mice tested for the effect of immunological restoration on the
incidence of lymphomas were exposed to 550 R irradiation, with either bone
marrow (Kaplan, Brown and Paull, 1953) or spleen (Lorenz, Congdon and Uphoff,
1953) shielding. The production by the irradiated mice of circulating antibody
to the Shigella antigen, inoculated at different intervals after the irradiation (to
evaluate the immunological reactivity following irradiation) was carried out as
previously described (Haran-Ghera and Peled, 1967). The homograft reaction
for testing the immunological impairment of the irradiated mice was determined
by using a solid fibrosarcoma which was induced originally by a subcutaneous
injection of 3,4-benzopyrene into C3H/Jax mice (Feldman and Globerson, 1964),
and since then serially transferred in isologous mice. The tumour was minced in
3 volumes of phosphate-buffered saline, and 0-2 ml. of the cell suspension was
injected intramuscularly into the right leg of the C57B1 mice tested.
RESULTS
Restoration ofimmurnological impairment and lymphoma development
The leukaemia induction rate in immunologically impaired mice versus the
incidence in immunologically restored animals was studied. The immunological
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suppression induced in mice by thymectomy and irradiation (550 R whole-body
exposure) was prevented or restored by either shielding of bone marrow or spleen
during irradiation, or by intravenous injection ofspleen and lymph node cells into
irradiated mice 2 hours after the X-ray exposure.
Male C57B1/6 micewerethymectomizedwhen 40 ± 5daysold, andthendivided
into 4 groups and given the following treatment:
A. Exposure to 550 R whole-body irradiation.
B. Bone marrow shieding during exposure to 550 R, using a lead strip of 5 mm.
thickness on the thighs.
C. Spleen shielding during exposure to 550 R, using a lead strip on the surgi-
cally exteriorized spleen.
D. Intravenous injection of spleen and lymph node cells (30 x 106 cells) from
isologous normal adult mice into host mice 2 hours after they had been
exposed to 550 R whole-body irradiation.
Twenty-four hours after the radiation treatment of the different groups, an
isologous newborn thymus was grafted under the kidney capsule of these thy-
mectomized irradiated mice, and 7 days thereafter 0 05 ml. of the leukaemogenic
cell-free filtrate was injected directly into the thymus graft (the kidney bearing the
graft was surgically exteriorized for this inoculation). Two additional control
groups were set aside: In group E, 0-05 ml. ofphosphate-buffered saline (the solu-
tion used for the filtrate preparation) was injected into the thymus implant of
thymectomized mice exposed to 550 R whole-body irradiation. In group F, the
whole-body exposure was omitted-the mice were thymectomized, grafted with a
newborn isologous thymus, and the leukaemogenic filtrate was injected directly
into the thymus graft.





Treatment of host Leukaemia incidence (days)
7 days 1 day 7 days
A. Thx 550 R W.B. i.r. Th GFF 31/35=88% 90
B. Thx 550 R B.M. shielded i.r. Th CFF 8/22=36% 150
C. Thx 550R spleen shielded i.r. Th CFF 8/30=27% 145
2 hours
D. Thx 550 R W.B.+spleen+L.N. cells* i.r. Th -CFF 14/25=56% 141
E. Thx 550 R W.B. i.r. Th PBS 1/50= 2% 168
F. Thx i.r. Th CFF 2/20=10% 128
Thx = Thymectomy.
W.B. = Whole-body exposure.
i.r. Th = Intrarenal newborn thymus implant.
CFF = Cell-free leukaemogenic filtrate.
B.M. = Bone marrow.
* 30 x 106 spleen and lymph node cells from adult donors injected intravenously.
The results are summarized in Table I. The leukaemogenic cell-free filtrate,
when injected into the thymus graft under the kidney capsule in thymectomized
mice exposed to 550 R whole-body irradiation, caused lymphatic leukaemia
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development in 88 per cent of the inoculated mice, at an average latent period of
90 days. The lymphomas observed were usually generalized, the thymic implant
was extremely enlarged and always leukaemic, and leukaemic infiltration was
usually noted also in the liver, spleen and lymph nodes. Restoration ofthe tran-
sient depression of immunological responsiveness by shielding of bone marrow
(tested experimentally in the previous communication by evaluating the antibody
production of bone marrow shielded irradiated mice to the Shigella antigen) or
spleen reduced the incidence oflymphatic leukaemia to 36 per cent (group B) and
27 per cent (group C), although the same filtrate was used as in group A, in which
88 per cent of the inoculated mice developed leukaemia. This difference was the
result of whole-body exposure versus shielded irradiation. Spleen and lymph
node cells injected shortly after inoculation, as another means ofrestoring immuno-
logical impairment, was less effective-56 per cent ofthe inoculated mice (group D)
developed lymphomas. Omitting irradiation of the host, but injecting the same
amount of the leukaemogenic filtrate into a thymus implant under the kidney
capsule, yielded a low lymphoma incidence-10 per cent (group F) versus 88 per
cent (group A) in the parallel group, which differed only in the host's exposure to
X-rays. The administration of 550 R whole-body irradiation to thymectomized
mice reimplanted thereafter with a newborn thymus under the kidney capsule
(group E), induced only 2 per cent lymphatic leukaemia.
Effect of X-ray dose in the host
The lymphoma incidence in relation to exposure of the host to X-ray dosage
was tested. Male and female mice, 6-7 weeks old, were thymectomized, and after
5-7 days were exposed to one ofthe following X-ray doses: 75 R x 2 or 170R x 4
at weekly intervals, or single doses of 150 R, 250 R, 300 R or 550 R. A control
group ofnon-irradiated mice was also included in this experiment. Within 1 week
after irradiation, a newborn isologous thymus was grafted under the kidney cap-
sule, and the leukaemogenic filtrate was injected into a 5-7 day old graft. The
lymphoma incidence in the mice exposed to different X-ray doses is summarized in
Table II. No variability in the induction rate was noted due to sex difference,
TABLE II.-Effect of X-ray Dose to Host on Lymphatic Leukaemia Incidence
Average latent period
X-ray dose to host* Leukaemia incidence (days)
8/50=16% 188
75 R x 2 13/46=28% . 186
150 R . 4/23=17% 152
250 R 15/31=50% . 181
300 R 18/28=64% . 174
550 R . 35/41 =85% . 116
170 R x 4 . 32/40=80% 102
* Treatment of host: Thymectomy, then whole-body irradiation,
followed by implant of newborn thymus under the kidney capsule and
inoculation of the leukaemogenic filtrate into the thymus graft.
and the results were therefore combined. The increased incidence in lymphoma
development was related to increase in X-ray dose. Low doses of X-rays, e.g.
75 R x 2 and 150 R, did not enhance the tumour incidence or its latency beyond
the control values. The effective minimal X-ray dose for this testing procedure
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was 250-300 R, which increased the leukaemia incidence to 50-69 per cent versus
16 per cent in the control animals, though the latent period (180 days) was still
similar to that of the control group. Exposure to 550 R whole-body irradiation
seemed to be most effective, yielding the high incidence of 85 per cent lymphomas
at a comparatively shorter latent period of 116 days versus 180 days in the control
group. Fractionated irradiation of 170 R x 4 whole-body exposure did not show
any preference to a single high dose-80 per cent of the tested mice developed
lymphomas at a mean latent period of 102 days.
Duration of radiation effectiveness
Having learnt from the previous experiment that 550 R whole-body irradiation
was the optimal dose for lymphoma development in the present testing system,
we wondered whether there was a time threshold for thymus grafting after host
irradiation. Seven-week-old male mice were thymectomized and exposed to
550 R whole-body irradiation, and thereafter grafted with a newbornthymus under
the kidney capsule at 9, 30, 60, 90 and 105 days after irradiation. The same
leukaemogenic filtrate preparation used throughout these experiments was injected
directly into a 7-day-old thymus graft. The control group, in which irradiation
of the host was omitted, was designed to show the leukaemogenic effect of the
filtrate in non-irradiated host mice.
TABLE III.-Persistence of the Radiation Effect in the Host
Average latent period
Treatment of host Leukaemia incidence (days)
1 day 9 days 7 days
Thx- 550 R i.r. Th- CFF . 20/24=83% 106
1 day 30 days 7 days
Thx - 550R i.r. Th- CFF . 11/18=61% 112
1 day 60 days 7 days
Thx 550 R i.r. Th- CFF . 7/18=40% 140
1 day 90 days 7 days
Thx 550 R i.r. Th CFF . 12/26=46% 130
1 day 105 days 7 days
Thx 550 R i.r. Th CFF . 4/18=22% 156
30 days 7 days
Thx i.r. Th COFF . 2/17=11% 145
Thx = Thymectomy.
i.r. Th = Intrarenal thymus graft.
CFF = Cell-free filtrate.
As seen in Table III, the 9 day interval for thymus grafting after irradiation
yielded an 83 per cent lymphoma incidence at an average latent period of 106
days. Postponing the thymus grafting to 30 days after irradiation decreased the
lymphoma incidence slightly to 61 per cent, whereas after an interval of 60-90
days, the incidence of lymphoma development was reduced to 40-46 per cent, as
compared to 83 per cent in hosts grafted 9 days after exposure to radiation.
Delaying the thymus grafting to 105 days after irradiation minimized the radiation
effect-only 22 per cent ofthe inoculated mice developed lymphomas, an incidence
similar to that obtained in non-irradiated control mice (11 per cent). No signifi-
cant differences were noted in the average latent period oftumour development in
the different test groups.
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Immunological impairment in the irradiated mice
Determination of the type of defects induced in the immunologically impaired
mice by thymectomy and radiation, was carried out by testing the following
systems:
(1) Circulating antibody production to Shigella antigen.
Male and female mice, 2 months old, were dividedinto 3 groups, and given the
following treatment:
A. Thymectomy followed by 550 R whole-body exposure.
B. Thymectomy alone.
C. Normal control mice.
These groups were immunized with Shigella antigen at intervals of 24 hours,
7, 14, 21 and 30 days after completion of the irradiation treatment; the sera were
collected 7 days after Shigella inoculation, and tested for agglutinating antibody
to Shigella.
TABLE IV.-Antibody Production by Irradiated C57Bl Mice
Inoculated with Shigella Antigen
Agglutinin titre at different intervals after irradiation:
, ~~~~~~~~~~A
8 days 14 days 21 days 30 days
10g2 of log2 of log2 of 10g2 of
titre titre titre titre
Treatment of mice (mean) S.E. (mean) S.E. (mean) S.E. (mean) S.E.
A. Thx + 550 R W.B. 3-5* 0 5 4-4 0 45 7-3 0-61 12 0-41
B. Thx. . 10-5 0-15 11-2 0-32 10-1 02 5 11 0-18
C. Normal . . 11-6 0-27 -- - 12-4 0-26
S.E. = Mean standard error.
W.B. = WVhole-body irradiation.
* 15 mice were used in each test group.
The results are summarized in Table IV. The immunological impairment
induced by 550 R whole-body irradiation was transient. Minimal antibody pro-
duction was found in these mice 8 days after irradiation, with a mean log2 titre of
3 5, as compared to 10-5 in the thymectomized non-irradiated mice, and 11.6 in
normal controls. The low titres persisted for about 8days afterirradiation; there-
after a gradual increase was noted, reaching full recovery at about 30 days after
irradiation.
(2) Homograft reaction to allogeneic grafts of a C3H/Jax transplantable fibro-
sarcoma.
Female mice, 5-7 weeks old, werethymectomized and within a week exposed to
550 R, 300 R or 75 R x 2 (at weekly intervals) whole-body irradiation. The
allogeneic cell suspension of a C3H/Jax transplantable fibrosarcoma was injected
into the host mice at different intervals after irradiation, as well as into thymec-
tomizednon-irradiated mice. The effect ofirradiation onpostponing or abolishing
the spontaneous reactivation of the homograft reaction against the genetically-
foreign C3H tumour is described in Table V. All the tumour grafts in the thymec-
tomized non-irradiated control mice were rejected, and none showed palpable
growth before their rejection. Thymectomized mice exposed to 550 R whole-body
irradiation displayed a state of suppression of the immune mechanism even at
90 days after irradiation: 12 out of 14 mice exhibited tumour growth, 7 of which
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TABLE V.-Immunological Reactivity of Thymectomized Irradiated C57Bl Mice to
Allogeneic Grafts of a C3H/Jax Fibrosarcorno
Mean time of Mean time of
Treatment of host No. oftakes/ Lethaltakes/ regression death
No. of mice No. of mice (days) (days)
7 days 9 days
Thx 550 R C3HT . 17/17 17/17 . . 36
Thx C3HT 0/17 . -
7 days 22 days
Thx - 550 R C3HT . 16/17 . 16/17 . . 51
Thx C3HT . 0/17 -
7 days 90 days
Thx 550 R C3HT . 12/14 . 7/14 . 17 . 47
Thx C3HT . 0/15 . .
7 days 1 day
Thx - 300 R C3HT 8/10 . 2/10 . 16 . 32
7 days 7 days
Thx 300 R C3HT . 6/10 . 0/10 21 . --
7 days 30 days
Thx 300 R C3HT . 7/9 . 2/10 . 15 . 61
9 days 45 days
Thx 300 R C3HT . 0/10
7 days 2 days
Thx 75 R x 2 C3HT. 0/20 . -
7 days 45 days
Thx 75 R x 2 C3HT. 0/15 . -
Thx = Thymectomy.
C3HT = C3H tumour graft (i.m.).
were lethal. At 9 and 22 day intervals in the 550 R exposure groups, all the
mice developed lethal tumour growth. Exposure of thymectomized mice to
300 R irradiation was less effective than the 550 R dose-no tumour growth was
noted at a 45-day interval, while shorter intervals resulted in 60-80 per cent of
the grafted mice developing temporary tumour growth, which then regressed
within 15-21 days after first becoming palpable. The low dose of 75 R x 2 did
not exert any effect on the immune mechanism of the irradiated mice.
Irradiation ofthe host after inoculation ofthe leukaemogenic agent into the thymus graft
We wished to test whether the irradiation ofthe host would also be effective if
applied after the inoculation of the leukaemogenic agent into the thymus graft.
Male C57B1 mice, 7-8 weeks old, were thymectomized and 2 days later implanted
with a newborn thymus under the kidney capsule. When the thymus graft was
7 days old the leukaemogenic filtrate was injected directly into these grafts. One
group ofthese mice was left without further treatment as a control group; 4 other
groups were exposed to 550 R whole-body irradiation at 8, 30, 60 or 90 days after
inoculation of the leukaemogenic agent. The effective potency of the leukaemo-
genic filtrate used in this experiment was tested in the usual way: thymectomized
mice were exposed to 550 R whole-body irradiation, thereafter a newborn thymus
was grafted under the kidney capsule, and the leukaemogenic agent was injected
into a 7-day-oldgraft. The possibleleukaemogenic effect oftheradiation exposure
on the thymus graft was also tested, by exposing thymectomized mice carrying a
15- or 37-day-old thymus graft in the kidney to 550 R whole-body irradiation.
The results are reported in Table VI. A similar high incidence of 95-100 per
cent leukaemia development, having a similar latent period of 100-120 days, was
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TABLE VI.-The Effect of Host Irradiation After Inoculation of Leukaemogenic
Filtrate into Thymus Graft
Average latent period
Treatment of host Leukaemiaincidence (days)
2 days 7 days
A. Thx ir. Th CFF . 3/15=20% 105
7 days 1 day 7 days
B. Thx 550 R W.B. i.r. Th :CFF . 19/20=95% 100
2 days 7 days 8 days
C. Thx i.r. Th CFF 550 R W.B. . 16/16=100% 120
2 days 15 days
D. Thx i.r. Th 550 R W.B. . 4/24=16% . 184
2 days 7 days 30 days
E. Thx i.r. Th- CFF 550 R W.B. . 9/15=60% 223
2 days 37 days
F. Thx i.r. Th 550 R W.B. . 0/13
2 days 7 days 60 days
G. Thx i.r.Th CFF 550RW.B. . 2/15=13% 265
2 days 7 days 90 days
H. Thx i.r. Th CFF 550 R W.B. . 3/15=20% . 140
Thx = Thymectomy.
i.r.Th=Intrarenal thymus graft.
CFF = Cell-free leukaemogenic filtrate.
W.B. W Whole-body exposure.
observed whether irradiation was performed shortly before or after inoculation of
the leukaemogenic filtrate (groups B and C), but when the irradiation was omitted
(group A), only 20 per cent ofthe inoculated mice developed lymphomas, at a mean
latent period of 105 days. The leukaemogenic effect of 550 R exposure to a non-
inoculated thymus graft was very mild-only 16 per cent ofthese mice developed
tumours (group D). Postponing the irradiation to 30 days after inoculation ofthe
filtrate produced a decrease in the leukaemia incidence to 60 per cent, and
lengthened the average latent period to 223 days (group E); the matching irra-
diated control group was negative (group F). Delaying the exposure to irradiation
to 60 or 90 days after inoculation ofthe leukaemogenic filtrate nullified its effective-
ness (groups G and H), the results being similar to those obtained in the non-
irradiated control group (group A).
DISCUSSION
Effective means for lymphoma induction by the leukaemogenic filtrable agent
isolated from irradiated C57B1 mice is its direct inoculation into the thymus of
neonatal C57B1 mice, or into the thymus graft of the thymectomized irradiated
adult host (Haran-Ghera, Lieberman and Kaplan, 1966). This testing system is
not effective in adult hosts when irradiation of the host is omitted, even though
the agent is inoculated into a thymus graft in a proliferative state with many large
and medium lymphocytes, which are considered by Kaplan (1961) to be the suscep-
tible thymocytes for neoplastic transformation. Irradiation could therefore be
proposed as an important factor in neoplastic transformation and/or proliferation,
perhaps by causing transient depression ofthe immune response ofthe host. This
assumption has been tested experimentally in the present studies, by observing the
effect ofimmune reactivation ofthe host versus immune impairment on lymphoma
induction, and its relation to X-ray dosage. Immune restoration ofthe irradiated
host submitted to 550 R irradiation with shielding of bone marrow or spleen
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decreased the lymphoma incidence when compared to whole-body exposure (27-36
per cent versus 88 per cent) (Table I). The injection of spleen and lymph node
cells shortly after irradiation, as another means for immune reactivation of the
host, was less effective in the present studies (56 per cent versus 88 per cent),
perhaps because the amount of cells injected was not sufficient.
It was also shown that the increase in lymphoma development was related to
dosage of X-ray exposure to the host (Table II): 150 R and smaller doses were
ineffective; 250-300 R were increasingly effective, and 550 R was maximally
effective, results that coincide with those of Taliaferro, Taliaferro and Jaroslow
(1964) onthe relation ofX-raydosage andimmune impairment. There seemsto be
a threshold dose of X-rays, similar to the minimal X-ray dose that can produce
transient immune depression, which is essential for neoplastic proliferation in the
present testing system. The results have indicated a parallelism between the
X-ray dosage that causes different degrees of immune impairment and lymphoma
incidence in the sensitive test system for lymphoma development used in the
present studies.
It is interesting to note thatfractionated irradiation (170 R x 4) didnot display
any preference to a single high dose exposure to the host, th-ough fractionated
irradiation is a more favourable method for radiation leukaemogenesis (Kaplan
and Brown, 1952), suggesting that this procedure may be related to one ofthe other
effects involved in radiation leukaemogenesis, such as thymus and bone marrow
injury.
Inthe present studies, 550 Rwhole-body irradiation wasfoundto bethe optimal
dose for lymphoma development in the testing system used. It was found that
this radiation dose has a prolonged effect on the host-even 90 days after exposure
to 550 R the thymectomized irradiated host was still susceptible to lymphoma
development when the leukaemogenic filtrate was injected into a several-day old
thymus grafted under the kidney capsule of this pretreated host (Table III).
On the assumption that the transient depression of the immunological response
induced by irradiation was the contributor to neoplastic proliferation, we wondered
whether this immune impairment induced by exposure of thymectomized mice to
550 R whole-body irradiation could persist for so long a period of about 3 months.
As the immunological impairment includes defects in circulating antibody forma-
tion, homograft rejection and the delayed type of hypersensitivity, and need not
be a generalized one, we tested these irradiated mice for defects in their capacity
to produce antibodies to the Shigella antigen, and also the homograft rejection
ability by these thymectomized irradiated mice of an allogeneic tumour graft.
The present experiments (Table IV) showed that 550 R whole-body irradiation of
thymectomized mice caused a marked decrease in antibody production to the
Shigella antigen (evaluated by the amount of agglutinin formation), but the low
titres persisted for about 8 days after irradiation; thereafter a gradual increase
was noted, reaching full recovery to normal values at about 30 days after irradia-
tion. These results did not coincide with our previous findings that the effect of
irradiation, contributing to neoplastic proliferation, persisted for a much longer
periodthan 30days, andledus to assume that anothertypeofdefectintheimmune
mechanism may be involved. Feldman and Globerson (1964) have shown that
thymectomy of adult mice followed by whole-body irradiation with sublethal
doses caused defects in their immune response-these mice could not reject allo-
geneic tumour tissue grafted into them 7 or 40 days after irradiation. We have
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applied this same testing system of an allogeneic tumour graft to a longer interval
of 90 days after irradiation (the effective time interval in the present testing
system), and to different radiation doses that were found to act differently on
lymphoma development. Indeed, the tests used in this study for homograft
reaction to allogeneic grafts ofa C3H/Jax transplantable sarcoma have shown that
thymectomized mice exposed to 550 R whole-body irradiation exhibited a state of
suppression of the immune mechanism. The allogeneic tumour grafted into
C57B1 mice 9 or 22 days after irradiation grew progressively and killed the host
mice, and even 90 days after the irradiation these thymectomized irradiated
(550 R) mice could still delay or abolishthe spontaneous homograftreaction against
genetically foreign tumours. The low dose of 75 R x 2 did not have any effect
on the host's immune mechanism, expressed by homograft rejection. The expo-
sure to 300 R was effective, though less so than the 550 R irradiation. An allo-
geneic tumour grafted into thymectomized C57B1 mice 1-30 days after their
exposure to 300 R, showed a 60-80 per cent tumour take, though many of these
tumours regressed within 15-20 days after first becoming palpable, whereas 45
days after exposure to 300 R all these allogeneic tumour grafts were rejected, as in
non-irradiated normal C57B1 mice. These results are in accord with our findings
(Haran-Ghera, 1967, unpublished observations) that thymectomized mice exposed
to 300 R develop a high incidence oflymphomas ifthe grafting and filtrate inocula-
tion are carried out within 1-30 days after irradiation. But postponing the testing
procedure to 45 days after irradiation nullifies the radiation effect, and the lym-
phoma induction rate in these mice is similar to that in non-irradiated control mice.
The results suggest that cellular immunity impairment of the homograft
reaction type, which is induced by irradiation of the host, and persists for several
months, may be involved in the neoplastic proliferation. Law, Ting and Leckband
(1966) have indicated that the most plausible explanation for polyoma virus
oncogenesis is related to the immunological capacity of the host, and that cellular
immunity of the homograft type produced against a virus-specific " tumour "
antigen, which is present in the neoplastic cells, is involved. The present results
may suggest a similar pathway for the leukaemogenic filtrable agent isolated from
irradiated tissues of C57B1 mice.
Following the results obtained on the important contribution of irradiation of
the host (before inoculation of the filtrate into the several-day old thymus graft)
in neoplastic proliferation, we wondered whether irradiation of the host would
also be effective if applied after the inoculation of the filtrate into the intrarenal
thymus graft, and if this is so, for how long could the irradiation of the host be
effectively delayed after virus inoculation. The present experiments indicated
that irradiation of the host was equally effective whether applied shortly before or
after thymus grafting and inoculation of the agent; but delaying the irradiation
to 30 days after inoculation ofthe filtrate caused a decrease in leukaemia incidence,
and lengthened the mean latent period of tumour development (Table VI).
When irradiation was applied to the host mice 60 or 90 days after injection of the
leukaemogenic filtrate, it had no effect on lymphoma induction-the tumour inci-
dence was similar to that in non-irradiated inoculated control mice. Whether
these variable results are due to loss ofviability and activity by the leukaemogenic
agent, or to some immune mechanism, is now under investigation.
In conclusion, the present results propose that transient depression of immuno-
logic responsiveness of the host, caused by its exposure to X-rays, may be an
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important factor in neoplastic transformation and/or proliferation induced by the
leukaemogenic transmissible agent isolated from irradiated C57B1 mouse tissues.
SUMMARY
Experimental evidence has been provided in support of the assumption that
radiation may contribute to X-ray leukaemogenesis in C57B1 mice, by causing
transient depression ofthe immune mechanism, in addition to its known effects on
thymus and bone marrow injury and the " release " of the leukaemogenic agent.
The use of the sensitive testing system of injecting the leukaemogenic filtrate
into a several-day-old thymus implant under the kidney capsule ofthymectomized
irradiated mice (550 R whole-body exposure) was essential in analysing this hypo-
thesis. In this testing system, ifirradiation was omitted, there was a very marked
reduction in the lymphoma incidence, even though the leukaemogenic agent was
inoculated into the test mice in abundance. Immune reactivation ofthe irradiated
hosts by bone marrow or spleen shielding, or by injection of spleen and lymph
node cells shortly after irradiation, caused a significant decrease in the incidence
of lymphoma induction. The rate of lymphoma development was related to
dosage of X-ray exposure to the host. The effective minimal X-ray dose for
tumour development was 250-300 R, while 550 R whole-body irradiation was
maximally effective, results that coincide with the relation of X-ray dosage to
induction of immune impairment. Studies to determine the type of the immune
defect caused by irradiation suggest that cellular immunity impairment of the
homograft reaction type may be involved in the neoplastic proliferation.
It has been shown that irradiation of the host was equally effective whether
applied shortly before or after agent inoculation, but delaying the radiation beyond
30 days after the leukaemogenic filtrate inoculation caused a progressive decrease
in the leukaemia incidence.
The author is indebted to Mrs. A. Peled for testing the production ofcirculating
antibodies in the irradiated mice, and to Mr. S. Yecheskel for his competent techni-
cal assistance.
REFERENCES
AxELRAD, A. A. AND VAN DER GAAG, H. C.-(1962) J. natn. Cancer In8t., 28, 1065.
FELDMAN, M. AND GLOBERSON, A.-(1964) Ann. N. Y. Acad. Sci., 120, 182.
GRoss, L.-(1958) Acta haemat., 19, 353.
HARAN-GHERA, N.-(1966) Int. J. Cancer, 1, 81.
HARAN-GHERA, N., LIEBERMAN, M. AND KAPLAN, H. S.-(1966) Cancer Res., 26, 438.
HARAN-GHERA, N. AND PELED, A.-(1967) Brit. J. Cancer, 21, 730.
JENKINS, V. K. AND UPTON, A. C.-(1963) Cancer Res., 23, 1748.
KAPLAN, H. S.-(1957) in 'The Leukemias, Etiology, Pathology and Treatment'.
New York (Academic Press), p. 163.-(1961) Cancer Res., 21, 981.-(1964)
Natn. Cancer Inst. Monogr., 14, 207.
KAPLAN, H. S. AND BROWN, M. B.-(1952) J. natn. Cancer Inst., 13, 185.
KAPLAN, H. S., BROWN, M. B. AND PAULL, J.-(1953) J. natn. Cancer Inst., 14, 303.
LAW, L. W., TING, R. C. AND LECKBAND, E.-(1966) in Ciba Fdn Symp. ' The Thymus'.
London (J. & A. Churchill, Ltd.), p. 214.
LIEBERMAN, M. AND KAPLAN, H. S.-(1959) Science, N.Y., 130, 387.
LORENZ, E., CONGDON, C. C. AND UPHOFF, D.-(1953) J. natn. Cancer Inst., 14, 291.
TALIAFERRO, W. H., TALIAFERRO, L. G. AND JAROSLOW, B. M.-(1964) in 'Radiation
and Immune Mechanism'. New York and London (Academic Press) p. 31.